Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.

We have studied the time course of recovery after administration of edrophonium during intense mivacurium block in children aged 2-10 yr, using thumb acceleration in response to train-of-four (TOF) stimulation. Forty-three children receiving alfentanil, propofol, nitrous oxide, isoflurane anaesthesia and mivacurium 0.2 mg kg-1 were allocated randomly to one of three groups. Patients in group 1 (n = 15) received edrophonium 1 mg kg-1, 2 min after maximum block (intense block group). At the time of administration of edrophonium in this group, there was no response to TOF stimulation (100% block) and the post-tetanic count was 10.7 (range 0-20). Patients in group 2 received the same dose of edrophonium after 10% recovery of the first twitch (T1) in the TOF (conventional reversal). Patients in group 3 (n = 13) recovered spontaneously. All patients developed complete suppression of twitch height in response to the bolus dose of mivacurium. All recovery times were measured from the point of maximum block after mivacurium. Mean time for 25% recovery of T1 (clinical duration) was 3.8 (SD 1.1) min in the intense block group. This was significantly shorter than the conventional reversal (8.3 (2.4) min) and spontaneous recovery (9.2 (3.5) min) groups (P < 0.001). The times for 75% and 90% recovery of T1 were shorter in the intense block group (9.4 (2.8), 12.3 (4.2) min) compared with the conventional (13.1 (3.8), 17.3 (4.8) min) and spontaneous recovery (14.9 (4.5), 17.9 (5.2) min) groups (P < 0.01). Total recovery time required for 70% recovery of the TOF ratio (T4/T1) was 8.8 (2.4) min in the intense block group. This was significantly shorter than the conventional reversal (11.9 (3.2) min) (P < 0.05) and spontaneous recovery (17.1 (4.0) min) groups (P < 0.001). Conventional reversal was associated with a shorter total recovery time compared with spontaneous recovery (P < 0.01). The recovery index (time interval between T1 25% and 75%) was comparable in groups 1-3 (5.5 (2.0), 4.8 (2.1) and 5.7 (1.4) min respectively). Ten minutes after development of maximum block, the numbers of patients who recovered adequately (TOF ratio 70% or more) were, respectively, 12 (80%), 8 (53%) and 1 (8%) in groups 1-3. We conclude that edrophonium antagonized intense (no response to TOF stimulation) mivacurium-induced block in children, with significant reduction in the recovery times of T1 and TOF ratio compared with conventional reversal and spontaneous recovery.

[1]  P. White,et al.  Reversal of neuromuscular blockade. , 1998, Anesthesia and analgesia.

[2]  M. Abdulatif.  Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block. , 1995, British Journal of Anaesthesia.

[3]  C. Lien,et al.  The Phamtacokinetics and Pharmacodynamics of the Stereoisomers of Mivacurium in Patients Receiving Nitrous Oxide/Opioid/Barbiturate Anesthesia , 1994, Anesthesiology.

[4]  A. Al-Ghamdi,et al.  Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. , 1993, British journal of anaesthesia.

[5]  J. Lunn,et al.  A comparison between mivacurium and suxamethonium in children , 1993, Anaesthesia.

[6]  D. Bevan.  Prolonged mivacurium-induced neuromuscular block. , 1993, Anesthesia and analgesia.

[7]  D. McTavish,et al.  Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia. , 1993, Drugs.

[8]  L. Skovgaard,et al.  Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. , 1993, Acta anaesthesiologica Scandinavica.

[9]  L. Skovgaard,et al.  Influence of plasma cholinesterase activity on recovery from mivacurium‐induced neuromuscular blockade in phenotypically normal patients , 1992 .

[10]  G. Hartman,et al.  ANTAGONISM OF MIVACURIUM BLOCKADE BY PURIFIED HUMAN BUTYRYL CHOLINESTERASE IN CATS , 1992 .

[11]  G. Meakin,et al.  Antagonism of intense atracurium-induced neuromuscular block in children. , 1991, British journal of anaesthesia.

[12]  A. Bjorksten,et al.  Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. , 1991, British journal of anaesthesia.

[13]  D. Silverman,et al.  Effect of tetanus on subsequent neuromuscular monitoring in patients receiving vecuronium. , 1991, Anesthesiology.

[14]  R. Miller,et al.  Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? , 1990, Anesthesiology.

[15]  D. R. Cook,et al.  Mivacurium Infusion Requirements in Pediatric Surgical Patients During Nitrous Oxide‐Halothane and During Nitrous Oxide‐Narcotic Anesthesia , 1990, Anesthesia and analgesia.

[16]  L. Skovgaard,et al.  Reversal of intense neuromuscular blockade following infusion of atracurium. , 1990, Anesthesiology.

[17]  N. Goudsouzian,et al.  Continuous infusion of mivacurium in children. , 1989, British journal of anaesthesia.

[18]  N. Goudsouzian,et al.  Neuromuscular and cardiovascular effects of mivacurium in children. , 1989, Anesthesiology.

[19]  B. Brandom,et al.  Clinical Pharmacology of Mivacurium Chloride (BW B1090U) in Children During Nitrous Oxide‐Halothane and Nitrous Oxide‐Narcotic Anesthesia , 1989, Anesthesia and analgesia.

[20]  H. Suzuki,et al.  Comparison between a new acceleration transducer and a conventional force transducer in the evaluation of twitch responses , 1988, Acta anaesthesiologica Scandinavica.

[21]  H. H. Ali,et al.  The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.

[22]  M. Werner,et al.  The acceleration transducer – an assessment of its precision in comparison with a force displacement transducer , 1988, Acta anaesthesiologica Scandinavica.

[23]  J. Viby Mogensen,et al.  Measurement of acceleration: a new method of monitoring neuromuscular function , 1988, Acta anaesthesiologica Scandinavica.

[24]  E. Robertson,et al.  Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. , 1986, British journal of anaesthesia.

[25]  A. Baraka,et al.  Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity. , 1981, British journal of anaesthesia.

[26]  R. Katz,et al.  Neuromuscular pharmacology. A clinical update and commentary. , 1980, British journal of anaesthesia.

[27]  M. Whittaker.  Plasma cholinesterase variants and the anaesthetist , 1980, Anaesthesia.

[28]  J. Norman.  Neuromuscular blocking drugs. , 1979, British journal of anaesthesia.